Comorbidities and Antithrombotic Treatment Pattern in Patients With Atrial Fibrillation
ConclusionsThe treatment pattern of antithrombotics did not change with the introduction of NOACs. However, comorbidities served as an important factor in choosing treatment regardless of NOAC entry.
Source: Frontiers in Neurology - Category: Neurology Source Type: research
More News: Atrial Fibrillation | Brain | Coumadin | Databases & Libraries | Health Insurance | Heart Attack | Insurance | Neurology | Stroke | Study | Vitamin K | Vitamins | Warfarin